Literature DB >> 28802207

The effect of aluminium and sodium impurities on the in vitro toxicity and pro-inflammatory potential of cristobalite.

C Nattrass1, C J Horwell2, D E Damby3, D Brown4, V Stone5.   

Abstract

BACKGROUND: Exposure to crystalline silica (SiO2), in the form of quartz, tridymite or cristobalite, can cause respiratory diseases, such as silicosis. However, the observed toxicity and pathogenicity of crystalline silica is highly variable. This has been attributed to a number of inherent and external factors, including the presence of impurities. In cristobalite-rich dusts, substitutions of aluminium (Al) for silicon (Si) in the cristobalite structure, and impurities occluding the silica surface, have been hypothesised to decrease its toxicity. This hypothesis is tested here through the characterisation and in vitro toxicological study of synthesised cristobalite with incremental amounts of Al and sodium (Na) dopants.
METHODS: Samples of synthetic cristobalite with incremental amounts of Al and Na impurities, and tridymite, were produced through heating of a silica sol-gel. Samples were characterised for mineralogy, cristobalite purity and abundance, particle size, surface area and surface charge. In vitro assays assessed the ability of the samples to induce cytotoxicity and TNF-α production in J774 macrophages, and haemolysis of red blood cells.
RESULTS: Al-only doped or Al+Na co-doped cristobalite contained between 1 and 4 oxide wt% Al and Na within its structure. Co-doped samples also contained Al- and Na-rich phases, such as albite. Doping reduced cytotoxicity to J774 macrophages and haemolytic capacity compared to non-doped samples. Al-only doping was more effective at decreasing cristobalite reactivity than Al+Na co-doping. The reduction in the reactivity of cristobalite is attributed to both structural impurities and a lower abundance of crystalline silica in doped samples. Neither non-doped nor doped crystalline silica induced production of the pro-inflammatory cytokine TNF-α in J774 macrophages.
CONCLUSIONS: Impurities can reduce the toxic potential of cristobalite and may help explain the low reactivity of some cristobalite-rich dusts. Whilst further work is required to determine if these effects translate to altered pathogenesis, the results have potential implications for the regulation of crystalline silica exposures.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cristobalite; Crystalline silica; Cytotoxicity; Haemolysis; Impurities

Mesh:

Substances:

Year:  2017        PMID: 28802207     DOI: 10.1016/j.envres.2017.07.054

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  11 in total

1.  Bioabsorbable high-purity magnesium interbody cage: degradation, interbody fusion, and biocompatibility from a goat cervical spine model.

Authors:  Xiuwu Guo; Haocheng Xu; Fan Zhang; Feizhou Lu
Journal:  Ann Transl Med       Date:  2020-09

2.  Volcanic Ash Activates the NLRP3 Inflammasome in Murine and Human Macrophages.

Authors:  David E Damby; Claire J Horwell; Peter J Baxter; Ulrich Kueppers; Max Schnurr; Donald B Dingwell; Peter Duewell
Journal:  Front Immunol       Date:  2018-01-22       Impact factor: 7.561

3.  The puzzling issue of silica toxicity: are silanols bridging the gaps between surface states and pathogenicity?

Authors:  Cristina Pavan; Massimo Delle Piane; Maria Gullo; Francesca Filippi; Bice Fubini; Peter Hoet; Claire J Horwell; François Huaux; Dominique Lison; Cristina Lo Giudice; Gianmario Martra; Eliseo Montfort; Roel Schins; Marialore Sulpizi; Karsten Wegner; Michelle Wyart-Remy; Christina Ziemann; Francesco Turci
Journal:  Part Fibre Toxicol       Date:  2019-08-16       Impact factor: 9.400

4.  Assessing the bioactivity of crystalline silica in heated high-temperature insulation wools.

Authors:  Matthew S P Boyles; David Brown; Jilly Knox; Michael Horobin; Mark R Miller; Helinor J Johnston; Vicki Stone
Journal:  Inhal Toxicol       Date:  2018-10-17       Impact factor: 2.724

5.  Chemical variability of artificial stone powders in relation to their health effects.

Authors:  Francesco Di Benedetto; Andrea Giaccherini; Giordano Montegrossi; Luca A Pardi; Alfonso Zoleo; Ferdinando Capolupo; Massimo Innocenti; Giovanni O Lepore; Francesco d'Acapito; Fabio Capacci; Carla Poli; Tonina Enza Iaia; Antonella Buccianti; Maurizio Romanelli
Journal:  Sci Rep       Date:  2019-04-25       Impact factor: 4.379

6.  Antioxidant Property of the Egyptian Propolis Extract Versus Aluminum Silicate Intoxication on a Rat's Lung: Histopathological Studies.

Authors:  Ali H Abu Almaaty; Yasmin M Abd El-Aziz; Nahed A Omar; Ahmed M Abdeen; Hala Afifi; Tarek S Ibrahim; Sameh S Elhady; Amgad I M Khedr
Journal:  Molecules       Date:  2020-12-10       Impact factor: 4.411

7.  Clear and Present Dangers: The Multiple Health Hazards of Volcanic Eruptions.

Authors:  Wendee Nicole
Journal:  Environ Health Perspect       Date:  2022-02-11       Impact factor: 9.031

8.  Characterisation of dust emissions from machined engineered stones to understand the hazard for accelerated silicosis.

Authors:  Chandnee Ramkissoon; Sharyn Gaskin; Leigh Thredgold; Tony Hall; Shelley Rowett; Richard Gun
Journal:  Sci Rep       Date:  2022-03-14       Impact factor: 4.379

9.  Assessment of the potential respiratory hazard of volcanic ash from future Icelandic eruptions: a study of archived basaltic to rhyolitic ash samples.

Authors:  David E Damby; Claire J Horwell; Gudrun Larsen; Thorvaldur Thordarson; Maura Tomatis; Bice Fubini; Ken Donaldson
Journal:  Environ Health       Date:  2017-09-11       Impact factor: 5.984

10.  Evaluation of Rhamnetin as an Inhibitor of the Pharmacological Effect of Secretory Phospholipase A2.

Authors:  Mariana Novo Belchor; Henrique Hessel Gaeta; Caroline Fabri Bittencourt Rodrigues; Caroline Ramos da Cruz Costa; Daniela de Oliveira Toyama; Luiz Felipe Domingues Passero; Marcia Dalastra Laurenti; Marcos Hikari Toyama
Journal:  Molecules       Date:  2017-08-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.